Literature DB >> 28439420

An unusual cause of fatal rapid-onset ataxia plus syndrome.

Ivan Kmezic1, Jan Weinberg1, Dan Hauzenberger2, Farouk Hashim3, Evangelia Kollia3, Monika Klimkowska4, Inger Nennesmo4, Martin Paucar1,5.   

Abstract

BACKGROUND: Progressive multifocal leukoencephalopathy (PML) is a demyelinating disorder of the central nervous system caused by reactivation of the JC-virus and is in most cases associated with underlying immunosuppression. Acquired immune deficiency syndrome (AIDS) and hematological malignancies are well-known predisposing factors for PML. However, in the past ten years, various pharmacological agents have been associated with increased risk of PML. Based on the phenomenology PML can be divided into the cerebral form and the rare cerebellar form. CASE
PRESENTATION: Here we describe a man affected by polycythemia vera (PCV) that was treated with hydroxyurea (HU) and developed PML. The initially PML presentation included ataxia as one of the main features. Brain MRI displayed widespread supratentorial and infratentorial lesions. Immunological analysis revealed absence of reactivity to a wide range of antigens. The course of disease was rapidly progressive with fatal outcome - autopsy ruled out leukemic transformation.
CONCLUSION: The occurrence of PML in PCV patients is very rare and has been reported only once. Movement disorders, such as ataxia, are also less frequent. In the present case the PML was likely multifactorial.

Entities:  

Keywords:  Ataxia; FASCIA analysis; Hydroxyurea; JC-virus; PML; Polycythemia vera

Year:  2017        PMID: 28439420      PMCID: PMC5399832          DOI: 10.1186/s40673-017-0063-9

Source DB:  PubMed          Journal:  Cerebellum Ataxias        ISSN: 2053-8871


Background

The association between polycythemia vera (PCV) and progressive multifocal leukoencephalopathy (PML) is very rare and has been reported only once [1]. This previously reported patient with PCV was treated with interferon (IFN)-α2B and thalidomide, but not hydroxyurea. In most cases PML is associated with immunodeficiency [2, 3]; however in very rare occasions it may also afflict immunocompetent patients [4]. The most frequent symptoms are motor weakness, changes in mentation and impaired vision [5], whereas movement disorders are less frequently seen [6].

Case presentation

An 81 year-old man presented with subacute disorientation, mild left-side weakness, impaired balance, apraxia and unilateral spatial neglect in May 2015. His past medical history included arterial hypertension and a stable course of PCV, diagnosed at the age of 66, treated with hydroxyurea (HU), low dose acetylsalicylic acid (ASA) and occasional phlebotomy. Upon admission in May 2015 a brain CT scan revealed a hypodense area in the right temporal lobe initially interpreted as a subacute infarction. Mild anemia was found and HU was discontinued. The patient was referred to a rehabilitation clinic, but his condition deteriorated rapidly in the following days. On readmission left-side weakness, marked contralateral limb ataxia, dysdiadochokinesia, bradykinesia, dysarthria, left homonymous hemianopia and left-sided hemianesthesia were evident. Brain MRI performed at this point displayed multifocal and punctate slightly expansive white matter non-contrast enhanced juxta- and subcortical lesions, predominantly in the right hemisphere. These lesions were more confluent around the right trigonum and within the right temporal lobe and brainstem. There was involvement of the right cerebral peduncle, anterior pons on the right side, right middle cerebellar peduncle and the cerebellum around the dentate nucleus. On diffusion-weighted imaging (DWI) lesions were hyperintense but without restricted diffusion as the apparent diffusion coefficients (ADC) were not decreased in the area (Fig. 1). EEG-recording revealed non-epileptiform abnormalities such as slow wave activities over right hemisphere and maximum over right temporal region.
Fig. 1

Brain MRI displaying PML features in a PCV patient treated with hydroxyurea. Axial and coronal T1-weighted sections displaying multifocal and confluent supra- and infratentorial lesions without contrast enhancement (arrows). There are also supratentorial punctate lesions (indicated by an arrow head). To the right T2-weigthed section displaying lesions in the right cerebellar hemisphere (arrow). No restricted diffusion

Brain MRI displaying PML features in a PCV patient treated with hydroxyurea. Axial and coronal T1-weighted sections displaying multifocal and confluent supra- and infratentorial lesions without contrast enhancement (arrows). There are also supratentorial punctate lesions (indicated by an arrow head). To the right T2-weigthed section displaying lesions in the right cerebellar hemisphere (arrow). No restricted diffusion A lumbar puncture was performed and yielded normal cell count and protein content in the cerebrospinal fluid (CSF). Enterovirus, herpes simplex 1 and 2, varicella zoster and CMV, were ruled out in the CSF by means of PCR and ELISA analysis. Serology for Lyme’s disease and syphilis in the CSF was also negative. Onconeural antibodies were not detected in blood. A centrifugated CSF sample was analyzed with fluorescence-activated cell sorting (FACS) which identified only few T-cells. Neurofilament light protein (NfL) was markedly elevated (16500 ng/L; reference interval <1850). Analysis for JC-virus yielded 7 400 copies/mL and tests for BK-virus, HIV, and HTLV-1 tests were negative. A second MRI of the brain three weeks after admission displayed an increased number of widespread supra- and infratentorial lesions (Fig. 2). Additional laboratory investigation at this point revealed mild lymphopenia with decreased amounts of all lymphocyte fractions but not NK-cells. A flow-cytometric assay of specific cell-mediated immune response in activated whole blood (FASCIA) analysis revealed poor response to mitogens and specific antigens as shown in table (Table 1).
Fig. 2

Brain MRI on day 38 of admission in a male with underlying PCV who developed PML. Axial T2-weighted sections display increased number of widespread and confluent supra- and infratentorial lesions. There were several “ring-shaped” lesions with hyperintensive periphery on DWI, increased central signal and isointense periphery on ADC. On T2-weighted images the lesions were globally hyperintense

Table 1

FASCIA analysis

AnalysisResultsReference interval
CD 4 PWM106233 – 2189 c/μL
CD 8 PWM550 – 549 c/μL
CD 19 PWM1742 – 741 c/μL
CD 4 ConA113620 – 3800 c/μL
CD 8 ConA1180 – 1757 c/μL
CD 4 Influenza019 – 1050 c/μL
CD 4 PPD011 – 2022 c/μL
CD 4 Candida051 – 1014 c/μL

Flow-cytometric assay of specific cell-mediated immune response in activated whole blood (FASCIA-analysis) revealed response absence of reactivity to a wide range of antigens. Response to lectins (pokeweed mitogen and concanavalin A) was moderately mitigated, whereas response to influenza antigen, purified protein derivative antigens and Candida antigen was completely absent

Brain MRI on day 38 of admission in a male with underlying PCV who developed PML. Axial T2-weighted sections display increased number of widespread and confluent supra- and infratentorial lesions. There were several “ring-shaped” lesions with hyperintensive periphery on DWI, increased central signal and isointense periphery on ADC. On T2-weighted images the lesions were globally hyperintense FASCIA analysis Flow-cytometric assay of specific cell-mediated immune response in activated whole blood (FASCIA-analysis) revealed response absence of reactivity to a wide range of antigens. Response to lectins (pokeweed mitogen and concanavalin A) was moderately mitigated, whereas response to influenza antigen, purified protein derivative antigens and Candida antigen was completely absent Different therapeutic options for PML were considered [7], but due to the rapid clinical deterioration treatment was withheld. The patient developed manifest left-sided hemiplegia, horizontal nystagmus, and verbal unresponsiveness. At this point his condition had worsened and the subject became unable to swallow, he contracted recurrent pneumonias and required a percutaneous endoscopic gastrostomy. During the later course of disease he remained in an unresponsive state until he died of pneumonia. Total disease duration in this case was two months. Post mortem studies of the bone marrow demonstrated a picture consistent with PCV but no signs of leukemic transformation. Histopathological analysis of the brain confirmed progressive multifocal leukoencephalopathy (PML) (Fig. 3).
Fig. 3

Histopathological findings. On coronal sections of the brain the white matter of the right temporal and frontal lobes was soft and its color grey-pink. Similar changes were also seen in the right cerebellar hemisphere (arrow head). On microscopy, widespread white matter lesions in those regions with destruction of myelin and the presence of large astrocytes and enlarged oligodendrocytes were evident. Some astrocytes had a bizarre appearance (arrow on picture below). Many similarly small white matter lesions were also present in the left cerebral hemisphere and the brainstem

Histopathological findings. On coronal sections of the brain the white matter of the right temporal and frontal lobes was soft and its color grey-pink. Similar changes were also seen in the right cerebellar hemisphere (arrow head). On microscopy, widespread white matter lesions in those regions with destruction of myelin and the presence of large astrocytes and enlarged oligodendrocytes were evident. Some astrocytes had a bizarre appearance (arrow on picture below). Many similarly small white matter lesions were also present in the left cerebral hemisphere and the brainstem

Discussion and Conclusions

PML is often a fatal disease as in this described case. It can be divided into the cerebral form which is more common and the cerebellar from. The latter can also affect the brainstem [8, 9]. Infratentorial PML is rare, and so far there are only 30 case reports of infratentorial PML in the PubMed database [10]. In the presented case the initial symptom was hemiplegia, but only within a few days a focal movement disorder, i.e. limb ataxia, became one of the main features of the patient’s condition. Very few sporadic cases of PML have been described and reported in individuals without obvious immunosuppression or immunosuppressive risk factors [6, 8]. The vast majority of PML infections affect immunosuppressed patients. A CD4 count below 200 cells/μL has been identified as a major risk factor for PML in deeply immunosuppressed patients with AIDS [11]. On the other hand, deleterious effects of hydroxyurea on CD4 lymphocytes have been described in children [12], but not in adults. In addition, myeloid malignancy such as PCV is not perceived as an immunosuppressive state. However, the natural process of immunological senescence involves both quantitative shifts and decreased functional capacity of various lymphocyte population subsets. Poor response of lymphocytes to mitogens can be seen in patients with immunological dysfunction or in patients with immunosuppressive treatments. The FASCIA results described here should therefore be interpreted in the context of a mild lymphopenia. In the described case, old age, myeloid malignancy and chemotherapy were likely the three factors that could have potentially contributed to JC-virus reactivation and development of a fatal disease. It is however difficult to pinpoint a single cause of PML in this case. Nevertheless, awareness of the potential consequences of such a constellation is important. PML should be considered as a differential diagnosis, especially in a PCV patient with rapidly progressive neurological symptoms without obvious immunosuppression or leukemic transformation.
  12 in total

1.  Primary cerebellar progressive multifocal leukoencephalopathy (PML) shows increased accumulation in (123)I-IMP SPECT.

Authors:  Shinjiro Fukami; Jiro Akimoto; Megumi Ichikawa; Hiroyuki Jimbo; Yukio Ikeda; Yohhei Ishimura; Kazunori Nanri; Kazuhiro Tsuchiya; Michihiro Kohno
Journal:  J Neurol Sci       Date:  2015-12-18       Impact factor: 3.181

Review 2.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

3.  Cerebellar form of progressive multifocal leukoencephalopathy (PML).

Authors:  J Parr; D S Horoupian; A C Winkelman
Journal:  Can J Neurol Sci       Date:  1979-05       Impact factor: 2.104

4.  Immunologic effects of hydroxyurea in sickle cell anemia.

Authors:  Howard M Lederman; Margaret A Connolly; Ram Kalpatthi; Russell E Ware; Winfred C Wang; Lori Luchtman-Jones; Myron Waclawiw; Jonathan C Goldsmith; Andrea Swift; James F Casella
Journal:  Pediatrics       Date:  2014-09-01       Impact factor: 7.124

Review 5.  The clinical features of PML.

Authors:  Joseph R Berger
Journal:  Cleve Clin J Med       Date:  2011-11       Impact factor: 2.321

Review 6.  Progressive multifocal leukoencephalopathy in patients with a hematological malignancy: review of therapeutic options.

Authors:  Alexander Kalisch; Martin Wilhelm; Frank Erbguth; Josef Birkmann
Journal:  Chemotherapy       Date:  2014-11-06       Impact factor: 2.544

7.  Autopsy case of the cerebellar form of progressive multifocal leukoencephalopathy without immunodeficiency.

Authors:  Yoshifumi Arai; Yoshihiro Tsutsui; Kazuo Nagashima; Yuichiro Shinmura; Tomoki Kosugi; Masakazu Wakai; Hirofumi Nishikage; Junnosuke Yamamoto
Journal:  Neuropathology       Date:  2002-03       Impact factor: 1.906

8.  Progressive multifocal leukoencephalopathy presenting with an isolated focal movement disorder.

Authors:  G Stockhammer; W Poewe; J Wissel; U Kiechl; H Maier; S Felber
Journal:  Mov Disord       Date:  2000-09       Impact factor: 10.338

Review 9.  Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.

Authors:  Sarah Gheuens; Gerald Pierone; Patrick Peeters; Igor J Koralnik
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10-14       Impact factor: 10.154

10.  Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.

Authors:  H Albrecht; C Hoffmann; O Degen; A Stoehr; A Plettenberg; T Mertenskötter; C Eggers; H J Stellbrink
Journal:  AIDS       Date:  1998-07-09       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.